Jyong Biotech Ltd., a science-driven biotechnology company, develops and commercializes plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops MCS-2 for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.
Dec 4, 2025, 8:30 AM EST - 14 days ago
Nov 24, 2025, 8:30 AM EST - 24 days ago
Nov 20, 2025, 8:30 AM EST - 4 weeks ago
Sep 29, 2025, 8:30 AM EDT - 2 months ago
Sep 18, 2025, 8:30 AM EDT - 3 months ago
Sep 16, 2025, 8:18 AM EDT - 3 months ago
Aug 22, 2025, 9:00 AM EDT - 4 months ago
Jul 26, 2025, 8:00 AM EDT - 5 months ago
Jul 22, 2025, 10:40 AM EDT - 5 months ago
Jun 22, 2025, 4:20 PM EDT - 6 months ago
ALAB ARM CAI EGG IPO IPOS JCAP
Jun 18, 2025, 5:20 PM EDT - 6 months ago
Jun 16, 2025, 11:38 PM EDT - 6 months ago
Feb 10, 2025, 3:42 PM EST - 11 months ago
Aug 18, 2023, 2:44 PM EDT - 2 years ago
Aug 17, 2023, 3:16 PM EDT - 2 years ago
Aug 17, 2023, 1:40 PM EDT - 2 years ago